60 Degrees Pharmaceuticals (SXTP) Return on Sales (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Return on Sales of 0.13% for Q1 2026, down 1.0% year-over-year from 0.13% in Q1 2025, and down 299.4% quarter-over-quarter from 0.03% in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Return on Sales (2022 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Return on Sales for 5 consecutive years, with 0.13% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Sales fell 1.0% year-over-year to 0.13%; the TTM figure through Mar 2026 stood at 0.07% (up 6.0% YoY), while the FY2025 annual figure was 0.07%, up 3.0% from the prior year.
- Return on Sales eased to 0.13% in Q1 2026 per SXTP's latest filing, from 0.03% in the prior quarter.
- Across five years, Return on Sales topped out at 0.82% in Q3 2023 and bottomed at 1.51% in Q1 2023.
- Historically, Return on Sales has averaged 0.13% across 5 years, with a median of 0.08% in 2023.
- On a YoY basis, Return on Sales climbed as much as 155 bps in 2024 and fell as far as 98 bps in 2024.
- 60 Degrees Pharmaceuticals' Return on Sales stood at 0.09% in 2022, then rose by 13 bps to 0.08% in 2023, then surged by 79 bps to 0.02% in 2024, then tumbled by 106 bps to 0.03% in 2025, then sank by 299 bps to 0.13% in 2026.
- Business Quant data shows SXTP's Return on Sales at 0.13% in Q1 2026, 0.03% in Q4 2025, and 0.05% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | -0.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.13% |
| Dec 31, 2025 | -0.03% |
| Sep 30, 2025 | -0.05% |
| Jun 30, 2025 | -0.17% |
| Mar 31, 2025 | -0.11% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.16% |
| Jun 30, 2024 | -0.33% |
| Mar 31, 2024 | 0.04% |
| Dec 31, 2023 | -0.08% |
| Sep 30, 2023 | 0.82% |
| Jun 30, 2023 | -0.08% |
| Mar 31, 2023 | -1.51% |
| Sep 30, 2022 | -0.09% |
| Jun 30, 2022 | -0.04% |